EHTH 📈 eHealth - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US28238P1093
EHTH: Health Insurance, Medicare Plans, Dental Plans, Vision Plans, Disability Insurance
eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Employer and Individual. The Medicare segment offers sale of Medicare-related health insurance plans, which includes Medicare advantage, Medicare Supplement, and Medicare Part D prescription drug plans to Medicare-eligible customers including but not limited to, dental, and vision insurance, as well as advertising program for marketing and other services. The Employer and Individual segment engages in the sale of individual, family, and small business health insurance plans; and ancillary products to non-Medicare-eligible customers including but not limited to, dental, vision, and short and long term disability insurance. In addition, the company provides ecommerce platforms and consumer engagement solutions, which includes market leading information, decision support, customer engagement, and transactional services to group of health insurance consumers; and organize and present the insurance information in objective format to individuals, families, and small businesses to research, analyze, compare and purchase health insurance plans. Further, it markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com. The company also offers online sponsorship and advertising, non-broker of record, lead referral, technology licensing, as well as performs various post-enrollment services for members in Medicare health insurance plans. eHealth, Inc. was incorporated in 1997 and is headquartered in Austin, Texas. Web URL: https://www.ehealthinsurance.com
Additional Sources for EHTH Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EHTH Stock Overview
Market Cap in USD | 167m |
Sector | Financial Services |
Industry | Insurance Brokers |
GiC Sub-Industry | Insurance Brokers |
IPO / Inception | 2006-10-13 |
EHTH Stock Ratings
Growth 5y | -90.2% |
Fundamental | -52.8% |
Dividend | - |
Rel. Strength Industry | -110 |
Analysts | 3.5/5 |
Fair Price Momentum | 6.36 USD |
Fair Price DCF | - |
EHTH Dividends
No Dividends PaidEHTH Growth Ratios
Growth Correlation 3m | 92.9% |
Growth Correlation 12m | -53.7% |
Growth Correlation 5y | -90.6% |
CAGR 5y | -38.47% |
CAGR/Mean DD 5y | -0.51 |
Sharpe Ratio 12m | 0.16 |
Alpha | -46.38 |
Beta | 1.43 |
Volatility | 167.21% |
Current Volume | 328.7k |
Average Volume 20d | 344.6k |
What is the price of EHTH stocks?
As of December 21, 2024, the stock is trading at USD 8.32 with a total of 328,655 shares traded.
Over the past week, the price has changed by +44.95%, over one month by +62.18%, over three months by +110.10% and over the past year by -3.37%.
As of December 21, 2024, the stock is trading at USD 8.32 with a total of 328,655 shares traded.
Over the past week, the price has changed by +44.95%, over one month by +62.18%, over three months by +110.10% and over the past year by -3.37%.
Is eHealth a good stock to buy?
No, based on ValueRay Fundamental Analyses, eHealth (NASDAQ:EHTH) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -52.82 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EHTH as of December 2024 is 6.36. This means that EHTH is currently overvalued and has a potential downside of -23.56%.
No, based on ValueRay Fundamental Analyses, eHealth (NASDAQ:EHTH) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -52.82 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EHTH as of December 2024 is 6.36. This means that EHTH is currently overvalued and has a potential downside of -23.56%.
Is EHTH a buy, sell or hold?
eHealth has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold EHTH.
eHealth has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold EHTH.
- Strong Buy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecast for EHTH stock price target?
According to ValueRays Forecast Model, EHTH eHealth will be worth about 7.1 in December 2025. The stock is currently trading at 8.32. This means that the stock has a potential downside of -14.66%.
According to ValueRays Forecast Model, EHTH eHealth will be worth about 7.1 in December 2025. The stock is currently trading at 8.32. This means that the stock has a potential downside of -14.66%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7 | -15.9% |
Analysts Target Price | 11.3 | 36.2% |
ValueRay Target Price | 7.1 | -14.7% |